One of the most widely used biomarkers in the field of cardiology is NT-proBNP [20,21], which allows the identification of patients with HF, as well as monitoring their response to treatment [9] and predicting the prognosis of patients with cardiovascular disorders [4,20]. This evidence concerns the gene NPPB and cardiovascular disorder.